4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-23-049704
Options or other derivatives
- Director acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Gheuens Sarah Director | 2023-09-21 | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | D | ||
Loading xslF345X05/ownership.xml…